WallStreetZenWallStreetZen

NASDAQ: PODD
Insulet Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for PODD

Based on 19 analysts offering 12 month price targets for Insulet Corp

Min Forecast
$144.00+9.12%
Avg Forecast
$180.11+36.48%
Max Forecast
$277.00+109.91%

Should I buy or sell PODD stock?

Based on 21 analysts offering ratings for Insulet Corp.

Buy
Strong Buy
6 analysts 28.57%
Buy
5 analysts 23.81%
Hold
9 analysts 42.86%
Sell
0 analysts 0%
Strong Sell
1 analysts 4.76%
Although PODD's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates PODD as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their PODD stock forecasts and price targets.

PODD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-08-06Find Out Why
lockedlocked$00.00+00.00%2026-08-06Find Out Why
lockedlocked$00.00+00.00%2026-08-06Find Out Why
lockedlocked$00.00+00.00%2026-08-06
lockedlocked$00.00+00.00%2026-08-06Find Out Why
Bernstein
Bottom 8%
8
BuyMaintains$175.00+32.62%2026-08-06Find out why
Benchmark
Top 28%
73
Strong BuyMaintains$185.00+40.19%2026-08-06
Stifel Nicolaus
Bottom 14%
14
Strong BuyMaintains$180.00+36.40%2026-08-06
Wells Fargo
Bottom 2%
2
HoldDowngrades$144.00+9.12%2026-08-06Find out why
JP Morgan
Top 22%
79
HoldDowngrades$152.00+15.19%2026-08-06Find out why

1 of 3

Forecast return on equity

Is PODD forecast to generate an efficient return?

Company
62.62%
Industry
22.17%
Market
167.71%
PODD's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PODD forecast to generate an efficient return on assets?

Company
28.14%
Industry
13.68%
PODD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PODD earnings per share forecast

What is PODD's earnings per share in the next 3 years based on estimates from 29 analysts?

Avg 1 year Forecast
$6.59+23.16%
Avg 2 year Forecast
$7.77+45.14%
Avg 3 year Forecast
$9.34+74.56%
PODD's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

PODD revenue forecast

What is PODD's revenue in the next 3 years based on estimates from 30 analysts?

Avg 1 year Forecast
$3.4B+9.87%
Avg 2 year Forecast
$3.8B+25.23%
Avg 3 year Forecast
$4.4B+42.89%
PODD's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PODD earnings growth forecast

How is PODD forecast to perform vs Medical Devices companies and vs the US market?

Company
20.07%
Industry
22.07%
Market
30.8%
PODD's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
PODD's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
PODD's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

PODD revenue growth forecast

How is PODD forecast to perform vs Medical Devices companies and vs the US market?

Company
12.51%
Industry
7.3%
Market
13.22%
PODD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PODD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PODD vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
PODD$131.96$180.11+36.48%Buy
GKOS$167.25$184.18+10.12%Strong Buy
BIO$369.32$328.00-11.19%Hold
GMED$74.19$99.00+33.44%Buy
BRKR$53.43$61.00+14.17%Buy
View Top Medical Device Stocks

Insulet Stock Forecast FAQ

Is Insulet Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 21 Wall Street analysts covering (NASDAQ: PODD) stock is to Buy PODD stock.

Out of 21 analysts, 6 (28.57%) are recommending PODD as a Strong Buy, 5 (23.81%) are recommending PODD as a Buy, 9 (42.86%) are recommending PODD as a Hold, 0 (0%) are recommending PODD as a Sell, and 1 (4.76%) are recommending PODD as a Strong Sell.

If you're new to stock investing, here's how to buy Insulet stock.

What is PODD's earnings growth forecast for 2026-2028?

(NASDAQ: PODD) Insulet's forecast annual earnings growth rate of 20.07% is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 22.07%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 30.8%.

Insulet's earnings in 2026 is $375,300,000.On average, 29 Wall Street analysts forecast PODD's earnings for 2026 to be $456,974,817, with the lowest PODD earnings forecast at $367,022,421, and the highest PODD earnings forecast at $478,439,942. On average, 29 Wall Street analysts forecast PODD's earnings for 2027 to be $538,535,355, with the lowest PODD earnings forecast at $329,640,508, and the highest PODD earnings forecast at $595,683,215.

In 2028, PODD is forecast to generate $647,678,058 in earnings, with the lowest earnings forecast at $380,615,844 and the highest earnings forecast at $751,522,100.

What is PODD's revenue growth forecast for 2026-2028?

(NASDAQ: PODD) Insulet's forecast annual revenue growth rate of 12.51% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.3%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.22%.

Insulet's revenue in 2026 is $3,053,500,000.On average, 30 Wall Street analysts forecast PODD's revenue for 2026 to be $232,683,337,645, with the lowest PODD revenue forecast at $216,870,580,273, and the highest PODD revenue forecast at $242,531,633,903. On average, 29 Wall Street analysts forecast PODD's revenue for 2027 to be $265,210,456,976, with the lowest PODD revenue forecast at $234,001,067,426, and the highest PODD revenue forecast at $279,636,130,368.

In 2028, PODD is forecast to generate $302,592,370,237 in revenue, with the lowest revenue forecast at $259,176,641,663 and the highest revenue forecast at $330,195,341,439.

What is PODD's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: PODD) forecast ROA is 28.14%, which is higher than the forecast US Medical Devices industry average of 13.68%.

What is PODD's Price Target?

According to 19 Wall Street analysts that have issued a 1 year PODD price target, the average PODD price target is $180.11, with the highest PODD stock price forecast at $277.00 and the lowest PODD stock price forecast at $144.00.

On average, Wall Street analysts predict that Insulet's share price could reach $180.11 by Aug 6, 2027. The average Insulet stock price prediction forecasts a potential upside of 36.48% from the current PODD share price of $131.96.

What is PODD's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: PODD) Insulet's current Earnings Per Share (EPS) is $5.35. On average, analysts forecast that PODD's EPS will be $6.59 for 2026, with the lowest EPS forecast at $5.29, and the highest EPS forecast at $6.90. On average, analysts forecast that PODD's EPS will be $7.77 for 2027, with the lowest EPS forecast at $4.75, and the highest EPS forecast at $8.59. In 2028, PODD's EPS is forecast to hit $9.34 (min: $5.49, max: $10.84).

What is PODD's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: PODD) forecast ROE is 62.62%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.